建新股份(300107.SZ)子公司2099.8萬元競得海域使用權
格隆匯2月13日丨建新股份(300107.SZ)公佈,公司全資子公司滄州升騰科技有限公司(“升騰科技”)近日參與了滄州渤海新區CB-2014-009-B宗海海域使用權的競拍,並收到《海域使用權成交確認書》,升騰科技以人民幣2099.8萬元競得該宗海域的使用權,位置:黃驊港綜合保税區內,用途:工業用海,面積:83657平方米,出讓年限:50年。
升騰科技購買的海域使用權主要充分利用保税區區位及政策優勢,發揮公司的產業基礎和資金實力,進一步拓展在新材料、複合材料、生物材料領域的研發及進出口貨物的倉儲、運輸業務,滿足戰略發展的需要。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.